Microfluidic Immunoassay Market is attracting attention from diagnostic companies, pharmaceutical researchers, and healthcare providers because of the potential to miniaturize conventional immunoassay workflows. Microfluidic platforms can bring multiple analytical functions onto a single chip, creating opportunities for compact systems with reduced sample volumes and improved automation.

Cardiology is an important application area, particularly for biomarker analysis. Microfluidic cartridges can support the measurement of cardiac biomarkers and other clinically relevant indicators, which can be valuable when healthcare professionals need information quickly. Research has also identified cardiology as a significant application segment within the market.

Pharmaceutical and biotechnology companies represent another important source of demand. Microfluidic immunoassays can assist with biomarker research, drug discovery, and development activities, while miniaturized testing can help researchers work with smaller quantities of valuable samples and reagents.

The next stage of market development is likely to focus on greater automation, multiplexed testing, portable analyzers, and improved detection technologies. Electrochemical methods are receiving particular attention because of their low power requirements and suitability for compact devices. As these systems become easier to manufacture and validate, their use could expand across clinical laboratories and decentralized healthcare settings.